MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Nystatin

Nystatin 100,000unit pessaries

No stability information

Stability notes for Nystatin 100,000unit pessaries

There are no stability notes for this medicine.

Suppliers

Nystatin 100,000unit pessaries (Sanofi)
Nystatin 100,000unit pessaries (Special Order)

Nystatin 250mg capsules

No stability information

Stability notes for Nystatin 250mg capsules

There are no stability notes for this medicine.

Supplier

Nystatin 250mg capsules (Special Order)

Nystatin 500,000unit tablets

No stability information

Stability notes for Nystatin 500,000unit tablets

There are no stability notes for this medicine.

Supplier

Nystatin 500,000unit tablets (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.